HEADER TRANSFERASE 27-NOV-07 2ZDT TITLE CRYSTAL STRUCTURE OF HUMAN JNK3 COMPLEXED WITH AN ISOQUINOLONE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 10; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES UNP 39-402; COMPND 5 SYNONYM: STRESS-ACTIVATED PROTEIN KINASE JNK3, C-JUN N-TERMINAL COMPND 6 KINASE 3, MAP KINASE P49 3F12; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET21ALPHA KEYWDS PROTEIN KINASE, ATP-BINDING, EPILEPSY, NUCLEOTIDE-BINDING, KEYWDS 2 PHOSPHOPROTEIN, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.SOGABE,Y.ASANO,S.FUKUMOTO,N.HABUKA,A.FUJISHIMA REVDAT 4 01-NOV-23 2ZDT 1 REMARK REVDAT 3 13-JUL-11 2ZDT 1 VERSN REVDAT 2 24-FEB-09 2ZDT 1 VERSN REVDAT 1 23-SEP-08 2ZDT 0 JRNL AUTH Y.ASANO,S.KITAMURA,T.OHRA,F.ITOH,M.KAJINO,T.TAMURA,M.KANEKO, JRNL AUTH 2 S.IKEDA,H.IGATA,T.KAWAMOTO,S.SOGABE,S.MATSUMOTO,T.TANAKA, JRNL AUTH 3 M.YAMAGUCHI,H.KIMURA,S.FUKUMOTO JRNL TITL DISCOVERY, SYNTHESIS AND BIOLOGICAL EVALUATION OF JRNL TITL 2 ISOQUINOLONES AS NOVEL AND HIGHLY SELECTIVE JNK INHIBITORS JRNL TITL 3 (2) JRNL REF BIOORG.MED.CHEM. V. 16 4699 2008 JRNL REFN ISSN 0968-0896 JRNL PMID 18313930 JRNL DOI 10.1016/J.BMC.2008.02.028 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1625443.960 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 26941 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.216 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1351 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4180 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE : 0.3560 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 208 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.025 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2774 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 162 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 14.75000 REMARK 3 B22 (A**2) : -8.23000 REMARK 3 B33 (A**2) : -6.52000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.28 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.34 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.780 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.110 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.100 ; 3.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.890 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.290 ; 4.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 58.93 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : SOLVENT.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : 718.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : SOLVENT.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : 718.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ZDT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1000027845. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-OCT-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL32B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU JUPITER 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26941 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.3 REMARK 200 DATA REDUNDANCY : 5.610 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.27 REMARK 200 R MERGE FOR SHELL (I) : 0.26900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1JNK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PENTAERYTHRITOL ETHOXYLATE (15/4 REMARK 280 EO/OH), 0.1M AMMONIUM SULFATE, 0.1M BIS-TRIS, PH 6.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.16550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.05150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.84350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.05150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.16550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.84350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 39 REMARK 465 SER A 40 REMARK 465 LYS A 41 REMARK 465 SER A 42 REMARK 465 LYS A 43 REMARK 465 VAL A 44 REMARK 465 ARG A 212 REMARK 465 THR A 213 REMARK 465 ALA A 214 REMARK 465 GLY A 215 REMARK 465 THR A 216 REMARK 465 GLN A 374 REMARK 465 ILE A 375 REMARK 465 TYR A 376 REMARK 465 ASP A 377 REMARK 465 LYS A 378 REMARK 465 GLN A 379 REMARK 465 LEU A 380 REMARK 465 ASP A 381 REMARK 465 GLU A 382 REMARK 465 SER A 401 REMARK 465 GLU A 402 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 140 -51.35 -129.84 REMARK 500 MET A 149 -157.77 -110.36 REMARK 500 ARG A 188 -10.99 75.23 REMARK 500 ASP A 189 40.81 -140.81 REMARK 500 LEU A 210 -41.71 161.44 REMARK 500 LYS A 241 -165.95 -123.15 REMARK 500 ALA A 320 46.15 -152.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 46C A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 902 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ZDU RELATED DB: PDB DBREF 2ZDT A 39 402 UNP P53779 MK10_HUMAN 39 402 SEQRES 1 A 364 MET SER LYS SER LYS VAL ASP ASN GLN PHE TYR SER VAL SEQRES 2 A 364 GLU VAL GLY ASP SER THR PHE THR VAL LEU LYS ARG TYR SEQRES 3 A 364 GLN ASN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY ILE SEQRES 4 A 364 VAL CYS ALA ALA TYR ASP ALA VAL LEU ASP ARG ASN VAL SEQRES 5 A 364 ALA ILE LYS LYS LEU SER ARG PRO PHE GLN ASN GLN THR SEQRES 6 A 364 HIS ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU MET LYS SEQRES 7 A 364 CYS VAL ASN HIS LYS ASN ILE ILE SER LEU LEU ASN VAL SEQRES 8 A 364 PHE THR PRO GLN LYS THR LEU GLU GLU PHE GLN ASP VAL SEQRES 9 A 364 TYR LEU VAL MET GLU LEU MET ASP ALA ASN LEU CYS GLN SEQRES 10 A 364 VAL ILE GLN MET GLU LEU ASP HIS GLU ARG MET SER TYR SEQRES 11 A 364 LEU LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU HIS SEQRES 12 A 364 SER ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER ASN SEQRES 13 A 364 ILE VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU ASP SEQRES 14 A 364 PHE GLY LEU ALA ARG THR ALA GLY THR SER PHE MET MET SEQRES 15 A 364 THR PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO GLU SEQRES 16 A 364 VAL ILE LEU GLY MET GLY TYR LYS GLU ASN VAL ASP ILE SEQRES 17 A 364 TRP SER VAL GLY CYS ILE MET GLY GLU MET VAL ARG HIS SEQRES 18 A 364 LYS ILE LEU PHE PRO GLY ARG ASP TYR ILE ASP GLN TRP SEQRES 19 A 364 ASN LYS VAL ILE GLU GLN LEU GLY THR PRO CYS PRO GLU SEQRES 20 A 364 PHE MET LYS LYS LEU GLN PRO THR VAL ARG ASN TYR VAL SEQRES 21 A 364 GLU ASN ARG PRO LYS TYR ALA GLY LEU THR PHE PRO LYS SEQRES 22 A 364 LEU PHE PRO ASP SER LEU PHE PRO ALA ASP SER GLU HIS SEQRES 23 A 364 ASN LYS LEU LYS ALA SER GLN ALA ARG ASP LEU LEU SER SEQRES 24 A 364 LYS MET LEU VAL ILE ASP PRO ALA LYS ARG ILE SER VAL SEQRES 25 A 364 ASP ASP ALA LEU GLN HIS PRO TYR ILE ASN VAL TRP TYR SEQRES 26 A 364 ASP PRO ALA GLU VAL GLU ALA PRO PRO PRO GLN ILE TYR SEQRES 27 A 364 ASP LYS GLN LEU ASP GLU ARG GLU HIS THR ILE GLU GLU SEQRES 28 A 364 TRP LYS GLU LEU ILE TYR LYS GLU VAL MET ASN SER GLU HET 46C A 901 32 HET GOL A 902 6 HETNAM 46C 4-[(6-CHLORO-1-OXO-4-PHENYL-3-PROPANOYLISOQUINOLIN- HETNAM 2 46C 2(1H)-YL)METHYL]BENZOIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 46C C26 H20 CL N O4 FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *162(H2 O) HELIX 1 1 PRO A 98 GLN A 100 5 3 HELIX 2 2 ASN A 101 VAL A 118 1 18 HELIX 3 3 LEU A 153 GLN A 158 1 6 HELIX 4 4 ASP A 162 ALA A 183 1 22 HELIX 5 5 LYS A 191 SER A 193 5 3 HELIX 6 6 ALA A 231 LEU A 236 1 6 HELIX 7 7 ASN A 243 HIS A 259 1 17 HELIX 8 8 ASP A 267 GLY A 280 1 14 HELIX 9 9 CYS A 283 LYS A 288 1 6 HELIX 10 10 GLN A 291 ARG A 301 1 11 HELIX 11 11 THR A 308 PHE A 313 1 6 HELIX 12 12 PRO A 314 PHE A 318 5 5 HELIX 13 13 SER A 322 LEU A 340 1 19 HELIX 14 14 SER A 349 HIS A 356 1 8 HELIX 15 15 ILE A 359 TYR A 363 5 5 HELIX 16 16 ASP A 364 GLU A 369 1 6 HELIX 17 17 THR A 386 MET A 399 1 14 SHEET 1 A 2 PHE A 48 VAL A 53 0 SHEET 2 A 2 SER A 56 LEU A 61 -1 O SER A 56 N VAL A 53 SHEET 1 B 5 TYR A 64 GLY A 73 0 SHEET 2 B 5 GLY A 76 ASP A 83 -1 O ALA A 80 N LYS A 68 SHEET 3 B 5 ARG A 88 SER A 96 -1 O ILE A 92 N CYS A 79 SHEET 4 B 5 ASP A 141 GLU A 147 -1 O MET A 146 N ALA A 91 SHEET 5 B 5 LEU A 126 PHE A 130 -1 N LEU A 127 O VAL A 145 SHEET 1 C 3 ALA A 151 ASN A 152 0 SHEET 2 C 3 ILE A 195 VAL A 197 -1 O VAL A 197 N ALA A 151 SHEET 3 C 3 LEU A 203 ILE A 205 -1 O LYS A 204 N VAL A 196 SITE 1 AC1 17 LYS A 68 ILE A 70 GLY A 71 SER A 72 SITE 2 AC1 17 VAL A 78 ALA A 91 MET A 146 GLU A 147 SITE 3 AC1 17 LEU A 148 MET A 149 ASP A 150 ALA A 151 SITE 4 AC1 17 ASN A 152 SER A 193 VAL A 196 LEU A 206 SITE 5 AC1 17 HOH A 986 SITE 1 AC2 6 ALA A 74 LYS A 191 TYR A 223 VAL A 225 SITE 2 AC2 6 THR A 226 HOH A1015 CRYST1 50.331 71.687 108.103 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019868 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013949 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009250 0.00000